^
Association details:
Biomarker:No biomarker
Cancer:Triple Negative Breast Cancer
Regimen:CaT (carboplatin + paclitaxel)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Invasive Breast Cancer: HER2 Negative…Other Recommended Regimens:…Select patients with TNBC in the preoperative setting only:...Weekly paclitaxel + carboplatin…